Zomedica Corp.: Zomedica Announces Third Quarter 2022 Financial Results: $4.78 Million Revenue; 75% Gross Margin & $158.49 Million in Cash, Cash Equivalents, and Available-For-Sale Securities

ANN ARBOR, MI / ACCESSWIRE / November 14, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company", a veterinary health company offering point-of-care diagnostics and therapeutic products

Related Keywords

Ann Arbor ,Michigan ,United States ,America ,American ,Kostenloser Wertpapierhandel ,Larry Heaton ,Instagram ,Walmart ,Linkedin ,Assisi Animal Health ,Twitter ,Zomedica Corp ,Zomedica Corp View ,Facebook ,Chief Executive Officer ,Pulse Veterinary Technologies ,Calmer Canine ,Small Animal Veterinarians ,Animal Veterinarian ,Third Quarter ,Outstanding Share ,Relations Contact ,Zomedica ,Orp ,Nnounces ,Third ,Quarter ,022 ,Financial ,Results ,Billion ,Revenue ,Cross ,Margin ,Cash ,Equivalents ,Vailable ,Sale ,Securities ,